American Fusion Restructures Up to $2.88 Million of Stock-Based Compensation Obligations into Long-Term, Lock-Up Preferred Equity and Begins Auditor Transition to MBP Global LLP

American Fusion agreed to exchange stock-based compensation rights covering a maximum contractual amount of $2.88 million for up to 288,000 Series C preferred shares across 12 officers, directors, consultants and advisors; the company said this is not a stated reduction in recorded liabilities, and accounting effects remain under review. Auditor JV CPA resigned effective October 1, citing health reasons, with no reported disagreements or reportable events; proposed successor MBP Global has not formally accepted the engagement. The company is pursuing institutional financing and a national exchange listing, both subject to execution and other uncertainties.

Analysis

The key read-through is financing optionality, not balance-sheet repair. The exchange may reduce pressure for cash compensation, but the stated $2.88 million maximum is not evidence that a recognized liability falls; until accounting treatment and the cap table are verified, investors should not credit it as deleveraging. If converted, the preferred can create common-share supply, with quarterly limits pacing rather than eliminating dilution. The eventual per-share impact depends on the fully diluted share count, conversion adjustments, vesting, and any financing-related issuance—none are established here.

The auditor handoff is a gating risk for the institutional-financing and uplisting narrative. No reported disagreement is reassuring but does not substitute for successor acceptance or a completed interim review. A delay could impair filing readiness and financing access; successful onboarding would remove a process overhang, not validate the fusion technology. The company’s own disclosure that the platform has not demonstrated ignition, net energy gain, or commercial generation argues against assigning near-term operating value to the technology claims.

Near term, expect headline-driven volatility with limited fundamental price discovery. Over 1–3 months, focus on auditor acceptance, review completion, accounting disclosure, and concrete listing/financing milestones. Over 6–18 months, dilution and execution risk dominate any commercial-upside case. Contrarian point: conversion restrictions may look protective, but they chiefly defer and schedule potential supply; they do not guarantee a higher common-stock value. No compelling trade is supported without liquidity, capitalization, and financing terms.

Key Decisions for Investors

• No immediate directional position: do not treat the preferred exchange as cash savings or a reduction in recorded liabilities. Verify the accounting conclusion and pro forma fully diluted share count before assigning value to the restructuring.
• Set an event alert for formal successor-auditor acceptance and completion/timing of the September-quarter review. A missed reporting or acceptance milestone weakens the financing/uplisting pathway; completion is a process positive, not evidence of technical progress.
• Before considering a long, require specific listing and institutional-financing terms, including price, size, and any warrant or conversion features, plus updated cash runway. Reassess only if those terms reduce near-term funding uncertainty without disproportionate dilution.
• Treat any sharp rally driven solely by uplisting language as a potential supply-risk window, not a short recommendation: confirm trading liquidity, borrow availability, conversion eligibility, and actual issuance data first. A material increase in conversion-related shares or a delayed audit process would falsify a constructive near-term setup.